Espinoza Octavio bought LGND
February 14, 2025 · Form 4 insider transaction
Espinoza Octavio bought 7,390 shares of Ligand Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,390
Price
$0.00
Total value
N/A
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 14, 2025
Filing dateFebruary 19, 2025
Shares owned after30,709
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock issued upon the vesting and certification of performance stock units (PSUs).